Biotech News
-
DIAGNOS Provides Market Activity Update
January 5, 2021 (Source) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader…
-
Sixth Wave Issues Common Shares to Pay Debenture Interest
January 4, 2021 (Source) — Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: ATURF) (FSE: AHUH) (“Sixth Wave” or the “Company”) has issued…
-
Hemostemix Announces Grant of Stock Options
January 4, 2021 (Source) — Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (“Hemostemix” or the “Company”) announces that, in…
-
StageZero Life Sciences, Ltd Announces Appointment of New Auditors
December 31, 2020 (Source) — StageZero Life Sciences, Ltd. (TSX:SZLS) (“StageZero” or the “Company”) announced today that it has…
-
Hemostemix Announces Closing of Unit Private Placement
December 31, 2020 (Source) — Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (“Hemostemix” or the “Company”) announces it has closed…
-
Sixth Wave Completes Convertible Debenture Financing and Repays Prior-Existing Debt
December 30, 2020 (Source) — Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: ATURF) (FSE: AHUH) (“Sixth Wave” or the “Company”) is pleased…
-
Hemostemix Announces Private Placement Update
December 29, 2020 (Source) — Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (“Hemostemix” or the “Company”) announces that it…
-
Valeo Pharma Announces DTC Eligibility for the Trading of Its Shares on the US OTCQB Market
December 29, 2020 (Source) — Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (“Valeo”), a Canadian pharmaceutical…
-
Hemostemix Announces Corporate Update
December 23, 2020 (Source) — Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (“Hemostemix” or the “Company”) The Company is pleased…
-
XPhyto Completes Successful SARS-CoV-2 RT-PCR Diagnostic Test Kit Validation
December 17, 2020 (Source) — XPhyto Therapeutics Corp. (CSE:XPHY / OTCQB:XPHYF / FSE:4XT) (“XPhyto” or the “Company”), a next-generation bioscience…
